skip to content

Dr Daniele Biasci

Selected publications:

Biasci, D., Smoragiewicz, M., Connell, C., Wang, Z., Gao, Y., Thaventhiran, J., Basu, B., Magiera, L., Johnson, I., Bax, L. and Gopinathan, A., 2020. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. medRxiv.

Biasci, Daniele, James Thaventhiran, and Simon Tavaré. "Fibroblastic reticular cells predict response to immune checkpoint inhibitors." BioRxiv (2020).

Biasci D, Lee JC, Noor NM, et al A blood-based prognostic biomarker in IBD Gut. (2019) 10.1136/gutjnl-2019-318343

Lee JC*, Biasci D*, et al. "Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease." Nature genetics. (2017) 49, no. 2: 262.

* Equal Contribution

Onorati M, Castiglioni V, Biasci D, et al. Molecular and functional definition of the developing human striatum. Nature neuroscience (2014), 17(12), 1804.

Richard AC, Lyons PA, Peters JE, Biasci D , et al. Comparison of gene expression microarray data with count-based RNA measurements informs microarray interpretation. BMC genomics (2014) Dec;15(1):649.

Tuijnenburg P, Allen HL, Burns SO, Greene D, Jansen MH, Staples E, Stephens J, Carss KJ, Biasci D, Baxendale H, Thomas M. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. Journal of Allergy and Clinical Immunology. (2018) Oct 1;142(4):1285-96.